iKena Oncology appoints Yarema as CEO of ImageneBio
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 23 2025
0mins
New Leadership Appointment: Ikena Oncology has appointed Kristin Yarema, Ph.D. as the Chief Executive Officer of ImageneBio following the anticipated closing of their merger.
Previous Experience: Dr. Yarema previously served as President and CEO at Poseida Therapeutics and was also a member of its Board of Directors.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
